Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Angle (AGL) Share News

IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval

25th May 2022 21:19

Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix system for use in metastatic breast cancer patients. Parasortix isolates circulating tumour cells from the blood which can aid in the diagnosis, characterisation and monitoring of cancer, and do so in a much less invasive fashion than traditional tissue biospy. Read More

LONDON MARKET CLOSE: Stocks rise ahead of US Fed meeting minutes

25th May 2022 17:06

(Alliance News) - Stocks in London ended mostly higher on Wednesday as market participants look ahead to the latest minutes from the US Federal Reserve at 1900 BST. Read More

IN BRIEF: Cancer study using Angle's Parasortix secures funding

20th May 2022 09:48

Angle PLC - Surrey, England-based medical diagnostics company - Says Prostate Cancer UK has given a GBP750,000 grant for a clinical study at Barts Cancer Institute, Queen Mary University of London. The trial will follow 200 men with localised prostate cancer over five years, assessed using Angle's Parsortix system, in bid to see whether the cancer will eventually spread. Read More

EARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss

28th Apr 2022 16:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

21st Apr 2022 16:10

TRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast

1st Apr 2022 12:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: Angle's Parsortix can help with cancer treatment options

29th Mar 2022 19:29

Angle PLC - Surrey, England-based medical diagnostics company - Notes University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute has published results of work undertaken in preclinical models of triple-negative breast cancer. Findings show isolation of live circulating tumour cells from a simple blood draw, using Angle's Parsortix system, can provide rapid information on patient response to existing chemotherapy treatments that can target metastasis more effectively than tumour growth. Read More

TRADING UPDATES: Europa eyes fundraise; Eastinco extends long stop

25th Mar 2022 18:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Angle US lab boost; Corcel to capitalise on nickel

18th Mar 2022 20:38

(Alliance News) - The following is a round-up of updates by London-listed companies, issued this week and not separately reported by Alliance News: Read More